{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:28:06Z","timestamp":1774542486941,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of the study was to determine the effect of sodium houttuyfonate on myocardial hypertrophy and its mechanism of action in mice and rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A mouse model of myocardial hypertrophy was established by subcutaneous injection with isoproterenol. Mice were randomly divided into five groups: normal control; isoproterenol control; isoproterenol plus metoprolol; isoproterenol plus low- and high-dose sodium houttuyfonate. A rat model of myocardial hypertrophy was established by intraperitoneal injection with l-thyroxine. Rats were randomly divided into five groups: normal control; l-thyroxine control; l-thyroxine plus captopril; l-thyroxine plus low- and high-dose sodium houttuyfonate. At the end of the experiments, the left ventricular weight index and heart weight index were determined in mice and rats, the size of cardiomyocytes was measured in rats and the concentrations of cAMP in plasma and angiotensin II in ventricular tissue of mice were detected by radioimmunoassay. The endothelin-1 concentration was measured by radioimmunoassay and the hydroxyproline content was measured by a digestive method in ventricular tissue of rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>After 7\u20139 days of treatment, sodium houttuyfonate significantly reduced the left ventricular weight index and heart weight index in mice and rats with myocardial hypertrophy, decreased the size of cardiomyocytes in rats, and reduced the content of cAMP and angiotensin II in mice with myocardial hypertrophy. It also decreased the endothelin-1 concentration and the hydroxyproline content in ventricular tissue in rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Sodium houttuyfonate can inhibit myocardial hypertrophy in mouse and rat models by restricting the activity of the sympathetic nervous system and decreasing the levels of angiotensin II and endothelin-1 in ventricular tissue.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1211\/jpp.61.05.0018","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T12:34:22Z","timestamp":1287059662000},"page":"677-683","source":"Crossref","is-referenced-by-count":21,"title":["Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats"],"prefix":"10.1093","volume":"61","author":[{"given":"Jian Ping","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Shanghai University of Traditional Chinese Medicine , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Xun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shanghai University of Traditional Chinese Medicine , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shanghai University of Traditional Chinese Medicine , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"L\u00fc","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shanghai University of Traditional Chinese Medicine , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Liang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shanghai University of Traditional Chinese Medicine , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"key":"2024103109372473700_cit1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"Am J Cardiol"},{"key":"2024103109372473700_cit2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.35.2.580","article-title":"Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension","volume":"35","author":"Schillaci","year":"2000","journal-title":"Hypertension"},{"key":"2024103109372473700_cit3","first-page":"30","article-title":"Synthesis of sodium houttuyfonate","volume":"20","author":"Yang","year":"2005","journal-title":"West China J Pharm Sci"},{"key":"2024103109372473700_cit4","first-page":"465","article-title":"Initial study on sodium houttuyfonate (injectable powder): antimicrobial activity in vitro","volume":"16","author":"Cheng","year":"2005","journal-title":"Lishizhen Med Materia Med Res"},{"key":"2024103109372473700_cit5","first-page":"119","article-title":"Antimicrobial activity of berberine hydrochloride, sodium houttuyfonate and allicin in vitro","volume":"21","author":"Zhao","year":"2005","journal-title":"Chin J Clin Pharmacol"},{"key":"2024103109372473700_cit6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1567-5769(02)00060-7","article-title":"Studies on adjuvanticity of sodium houttuyfonate and its mechanism","volume":"2","author":"Wang","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"2024103109372473700_cit7","first-page":"61","article-title":"Clinical application of herba houttuyniae injection","volume":"4","author":"Wang","year":"1999","journal-title":"Beijing J Tradit Chin Med"},{"key":"2024103109372473700_cit8","first-page":"45","article-title":"Observation on the effect of herba houttuyniae injection treatment in cases with pulmonary heart disease (in acute period) through atomizing inhalation","volume":"32","author":"Gan","year":"2004","journal-title":"J Chin Physician"},{"key":"2024103109372473700_cit9","first-page":"369","article-title":"Observation on the effect of herba houttuyniae injection treatment in 92 cases with pulmonary heart disease","volume":"9","author":"Guan","year":"2004","journal-title":"J Clin Pulmonary Med"},{"key":"2024103109372473700_cit10","first-page":"387","article-title":"Experimental study on herba houttuyniae injection against myocardial injury induced by endotoxin","volume":"20","author":"Wang","year":"2004","journal-title":"Chin J Pathophysiol"},{"key":"2024103109372473700_cit11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.HYP.33.1.396","article-title":"Beta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation","volume":"33","author":"Iaccarino","year":"1999","journal-title":"Hypertension"},{"key":"2024103109372473700_cit12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/jmcc.2000.1332","article-title":"Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart","volume":"33","author":"Morisco","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"2024103109372473700_cit13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y04-137","article-title":"Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure","volume":"83","author":"Hohimer","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"2024103109372473700_cit14","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"2024103109372473700_cit15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","article-title":"Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy","volume":"108","author":"Schlaich","year":"2003","journal-title":"Circulation"},{"key":"2024103109372473700_cit16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/CIRCULATIONAHA.106.668863","article-title":"Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension","volume":"115","author":"Burns","year":"2007","journal-title":"Circulation"},{"key":"2024103109372473700_cit17","first-page":"88","article-title":"Neurohumoral activation and remodeling after acute myocardial infarct and the effect of angiotensin-converting enzyme inhibitors","volume":"94","author":"D\u00fabrava","year":"1993","journal-title":"Bratisl Lek Listy"},{"key":"2024103109372473700_cit18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1027351808326","article-title":"Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy","volume":"17","author":"Remme","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"2024103109372473700_cit19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.11.1.3","article-title":"Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover","volume":"11","author":"Esler","year":"1988","journal-title":"Hypertension"},{"key":"2024103109372473700_cit20","first-page":"281","article-title":"Experimental cardiac hypertrophy induced by isoproterenol in the rat","volume":"46","author":"Szab\u00f3","year":"1975","journal-title":"Acta Physiol Acad Sci Hung"},{"key":"2024103109372473700_cit21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/y84-061","article-title":"Development of isoproterenol-induced cardiac hypertrophy","volume":"62","author":"Taylor","year":"1984","journal-title":"Can J Physiol Pharmacol"},{"key":"2024103109372473700_cit22","first-page":"311","article-title":"Catecholamine induced cardiac hypertrophy","volume":"3","author":"Tang","year":"1987","journal-title":"Can J Cardiol"},{"key":"2024103109372473700_cit23","first-page":"H1496","article-title":"Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats","volume":"267","author":"Golomb","year":"1994","journal-title":"Am J Physiol"},{"key":"2024103109372473700_cit24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005344-200208000-00010","article-title":"Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis","volume":"40","author":"Ocaranza","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"2024103109372473700_cit25","doi-asserted-by":"crossref","first-page":"205S","DOI":"10.1016\/S0895-7061(99)00103-X","article-title":"The renin-angiotensin-aldosterone system: a specific target for hypertension management","volume":"12","author":"Weir","year":"1999","journal-title":"Am J Hypertens"},{"key":"2024103109372473700_cit26","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/61.suppl_2.S4","article-title":"Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure","volume":"61","author":"Adams","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"key":"2024103109372473700_cit27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin-angiotensin-aldosterone system in vascular remodeing and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J Hypertens"},{"key":"2024103109372473700_cit28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr Rev"},{"key":"2024103109372473700_cit29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"2024103109372473700_cit30","first-page":"8","article-title":"Regulation of RNA synthesis in the rat heart in L-thyroxine toxicosis and hypothyroidism; the role of RNA-polymerases and the template activity of chromatin","volume":"58","author":"Karsanov","year":"1986","journal-title":"Ukr Biokhim Zh"},{"key":"2024103109372473700_cit31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00428-004-1175-1","article-title":"Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone \u2014 an acute study in rats","volume":"446","author":"Hu","year":"2005","journal-title":"Virchows Arch"},{"key":"2024103109372473700_cit32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.RES.43.5.688","article-title":"Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats","volume":"43","author":"Sanford","year":"1978","journal-title":"Circ Res"},{"key":"2024103109372473700_cit33","first-page":"398","article-title":"Spironolactone effects on myocardium changes induced by thyroid hormone in rats","volume":"89","author":"Fernandes","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"2024103109372473700_cit34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1677\/joe.0.1740111","article-title":"Metabolism of thyroid hormones in cultured cardiac fibroblasts of neonatal rats","volume":"174","author":"Heide","year":"2002","journal-title":"J Endocrinol"},{"key":"2024103109372473700_cit35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: therapeutic target in myocardial remodeling and failure","volume":"45","author":"Brown","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2024103109372473700_cit36","first-page":"345","article-title":"Correlation between plasma level of endothelin-1 and heart remodeling in dilated cardiomyopathy","volume":"111","author":"St\u00e4tineanu","year":"2007","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"2024103109372473700_cit37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1054\/jcaf.2003.39","article-title":"Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure","volume":"9","author":"Kinugawa","year":"2003","journal-title":"J Card Fail"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.61.05.0018","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/61\/5\/677\/60257901\/jpp.61.05.0018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/61\/5\/677\/60257901\/jpp.61.05.0018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:01:38Z","timestamp":1730368898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/61\/5\/677\/6136034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":37,"aliases":["10.1211\/jpp\/61.05.0018"],"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,1]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.61.05.0018","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,5]]},"published":{"date-parts":[[2009,5,1]]}}}